Efficacy of Jiedu Tongluo Tiaogan Formula on Type 2 Diabetic Lower Extremity Arteriosclerosis Obliterans: Study Protocol for a Metabolomics-Based Randomized Controlled Clinical Trial
View ORCID ProfileTianjiao Liu, View ORCID ProfileChunli Piao, View ORCID ProfileYuting Peng, View ORCID ProfileJinghan Xu, View ORCID ProfileYue Qu, Qi Li, Xiaohua Zhao, Xuemin Wu, Pei Li, Yawen Fan
doi: https://doi.org/10.1101/2022.06.25.22276893
Tianjiao Liu
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Chunli Piao
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Yuting Peng
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Jinghan Xu
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Yue Qu
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Qi Li
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Xiaohua Zhao
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Xuemin Wu
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Pei Li
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
Yawen Fan
1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China

- SPIRIT checklist[supplements/276893_file02.docx]
Posted June 27, 2022.
Efficacy of Jiedu Tongluo Tiaogan Formula on Type 2 Diabetic Lower Extremity Arteriosclerosis Obliterans: Study Protocol for a Metabolomics-Based Randomized Controlled Clinical Trial
Tianjiao Liu, Chunli Piao, Yuting Peng, Jinghan Xu, Yue Qu, Qi Li, Xiaohua Zhao, Xuemin Wu, Pei Li, Yawen Fan
medRxiv 2022.06.25.22276893; doi: https://doi.org/10.1101/2022.06.25.22276893
Efficacy of Jiedu Tongluo Tiaogan Formula on Type 2 Diabetic Lower Extremity Arteriosclerosis Obliterans: Study Protocol for a Metabolomics-Based Randomized Controlled Clinical Trial
Tianjiao Liu, Chunli Piao, Yuting Peng, Jinghan Xu, Yue Qu, Qi Li, Xiaohua Zhao, Xuemin Wu, Pei Li, Yawen Fan
medRxiv 2022.06.25.22276893; doi: https://doi.org/10.1101/2022.06.25.22276893
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)